Form 8.3 - AON PLC
BARCLAYS PLC
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) |
Barclays PLC. |
Company dealt in |
AON PLC |
Class of relevant security to which the dealings being disclosed relate (Note 2) |
ORD |
Date of dealing |
14 JULY 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) |
Relevant securities | ||||
241,376 |
0.10% |
1,497,694 |
0.65% |
||
(2) |
Derivatives (other than options): | ||||
529,637 |
0.23% |
29,700 |
0.01% |
||
(3) |
Options and agreements to | ||||
purchase/sell: |
2,600 |
0.00% |
4,500 |
0.00% |
|
(4) |
TOTAL: | ||||
773,613 |
0.33% |
1,531,894 |
0.66% |
||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: |
Long |
Short |
||||
|
Number |
|
(%) |
Number |
|
(%) |
(1) Relevant securities |
|
|
||||
(2) Derivatives (other than options) |
|
|
||||
(3) Options and agreements to purchase/sell |
|
|
||||
Total |
|
|
||||
|
Ap20
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale |
Number of relevant securities |
Price per unit |
Purchase |
1 |
199.1900 USD |
Purchase |
3 |
198.1566 USD |
Purchase |
3 |
198.2366 USD |
Purchase |
3 |
198.7100 USD |
Purchase |
3 |
198.6900 USD |
Purchase |
4 |
198.3875 USD |
Purchase |
6 |
198.3150 USD |
Purchase |
8 |
198.4725 USD |
Purchase |
9 |
198.4522 USD |
Purchase |
14 |
198.4214 USD |
Purchase |
22 |
198.4995 USD |
Purchase |
22 |
198.4372 USD |
Purchase |
27 |
198.5214 USD |
Purchase |
38 |
198.5947 USD |
Purchase |
47 |
200.9500 USD |
Purchase |
52 |
198.1600 USD |
Purchase |
63 |
199.1500 USD |
Purchase |
100 |
197.6500 USD |
Purchase |
100 |
198.2100 USD |
Purchase |
100 |
200.8500 USD |
Purchase |
105 |
199.2011 USD |
Purchase |
132 |
198.6993 USD |
Purchase |
133 |
198.4879 USD |
Purchase |
150 |
197.9050 USD |
Purchase |
175 |
197.9250 USD |
Purchase |
201 |
198.9852 USD |
Purchase |
300 |
198.6033 USD |
Purchase |
472 |
199.3517 USD |
Purchase |
700 |
198.3700 USD |
Purchase |
904 |
199.1055 USD |
Purchase |
1,053 |
199.1222 USD |
Purchase |
1,664 |
199.0058 USD |
Purchase |
1,965 |
199.0477 USD |
Purchase |
2,003 |
198.5889 USD |
Purchase |
2,393 |
198.6974 USD |
Purchase |
3,044 |
199.0315 USD |
Purchase |
3,259 |
198.9437 USD |
Purchase |
5,094 |
199.0500 USD |
Purchase |
7,252 |
198.7902 USD |
Purchase |
15,666 |
198.7946 USD |
Purchase |
19,682 |
198.8326 USD |
Sale |
3 |
198.6900 USD |
Sale |
52 |
198.1600 USD |
Sale |
69 |
199.3800 USD |
Sale |
75 |
198.1100 USD |
Sale |
87 |
199.0000 USD |
Sale |
100 |
197.9400 USD |
Sale |
100 |
199.4050 USD |
Sale |
100 |
198.6700 USD |
Sale |
132 |
198.6993 USD |
Sale |
133 |
198.4880 USD |
Sale |
133 |
198.4879 USD |
Sale |
147 |
200.8819 USD |
Sale |
150 |
197.9050 USD |
Sale |
201 |
198.9852 USD |
Sale |
238 |
198.7319 USD |
Sale |
300 |
198.6033 USD |
Sale |
300 |
198.4300 USD |
Sale |
315 |
198.6276 USD |
Sale |
376 |
199.8510 USD |
Sale |
987 |
198.7500 USD |
Sale |
1,103 |
198.2817 USD |
Sale |
1,203 |
199.0566 USD |
Sale |
2,017 |
198.4823 USD |
Sale |
2,477 |
198.7074 USD |
Sale |
2,894 |
198.2846 USD |
Sale |
3,207 |
199.0082 USD |
Sale |
9,194 |
199.0500 USD |
Sale |
13,071 |
198.9764 USD |
Sale |
29,449 |
198.8360 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD |
Nature of transaction (Note 6) |
Number of relevant securities (Note 7) |
Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option |
Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) |
Exercise price |
Type, e.g. American, European etc. |
Expiry date |
Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option |
Number of securities |
Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) |
Details |
Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) YES/NO
Date of disclosure |
15 JULY 2020 |
Contact name |
Large Holdings Regulatory Operations |
Telephone number |
020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected |
|
If a connected EFM, state nature of connection (Note 10) |
|
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name | Written or | Number of | Exercise | Type | Expiry |
purchased | relevant securities | price | date | ||
to which the option | |||||
or derivative | |||||
relates | |||||
Call Options | Purchased |
1,100 |
260.0000 |
American | Jul 17, 2020 |
Call Options | Purchased |
1,500 |
240.0000 |
American | Jul 17, 2020 |
Call Options | Written |
-4,500 |
220.0000 |
American | Jul 17, 2020 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200715005417/en/